MLchartDataset catalogue

Myc inhibitor OMO-103

Term · Oncology and biomedicine · MLC-T-ONC-015388

A peptide inhibitor of the proto-oncogene Myc, with potential antineoplastic activity. Upon administration, Myc inhibitor OMO-103 enters cells, reaches the nucleus and inhibits Myc. This may inhibit tumor cell growth and proliferation. Myc, a proto-oncogene dysregulated in a variety of cancers, plays a role in the regulation of transcription and cell proliferation.

Table 1. Record
IdentifierMLC-T-ONC-015388
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015388",
  "term": "Myc inhibitor OMO-103",
  "field": "Oncology and biomedicine",
  "definition": "A peptide inhibitor of the proto-oncogene Myc, with potential antineoplastic activity. Upon administration, Myc inhibitor OMO-103 enters cells, reaches the nucleus and inhibits Myc. This may inhibit tumor cell growth and proliferation. Myc, a proto-oncogene dysregulated in a variety of cancers, plays a role in the regulation of transcription and cell proliferation.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/myc-inhibitor-omo-103/"
}

Record 11,489 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.